Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire

@article{Ackah1995ResponseTT,
  title={Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, C{\^o}te d'Ivoire},
  author={Alain Ackah and Hippolyte Digbeu and K Daillo and Alan E. Greenberg and Daouda Coulibaly and Issa Malick Coulibaly and Kathleen M Vetter and Kevin M. De Cock},
  journal={The Lancet},
  year={1995},
  volume={345},
  pages={607-610}
}
Radiologic manifestations of pulmonary tuberculosis in HIV-1 and HIV-2-infected patients in Abidjan, Côte d'Ivoire.
  • L. Abouya, I. Coulibaly, K. D. de Cock
  • Medicine, Biology
    Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
  • 1995
High Mortality and Severe Immunosuppression in Hospitalized Patients with Pulmonary Tuberculosis and HIV-2 Infection in Guinea-Bissau
The aim of this study was to prospectively compare the clinical outcomes in HIV-2-infected and HIV-negative patients with culture-confirmed pulmonary tuberculosis, evaluate immunological changes and
High mortality and severe immunosuppression in hospitalized patients with pulmonary tuberculosis and HIV-2 infection in Guinea-Bissau.
TLDR
A significantly higher mortality rate in HIV-2-positive compared to HIV-negative individuals is found and in a multivariate logistic regression analysis a value of CD4 percentage of < 10 was shown to be an independent predictor of decreased survival in HIV -2-infected subjects.
WHO clinical staging of HIV infection and disease, tuberculosis and eligibility for antiretroviral treatment: relationship to CD4 lymphocyte counts.
  • R. Teck, O. Ascurra, R. Zachariah
  • Medicine, Biology
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
  • 2005
TLDR
Nine of 10 HIV-positive individuals presenting in WHO Stage III and IV and with active or previous TB have CD4 counts of < or = 350 cells/microl, and it would be reasonable, in this or similar settings whereCD4 counts are unavailable for clinical management, for all such patients to be considered eligible for antiretroviral therapy.
Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2
TLDR
Adjusted for CD4 cell count, incidence of TB was similar among HIV-1- and HIV-2-infected patients and mortality rates after TB diagnosis were similar in both groups and high compared with those without TB.
Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV‐infected adults in Abidjan, Côte d'Ivoire
TLDR
It is shown that most HIV-infected individuals admitted to and dying in hospital in Abidjan are profoundly immunosuppressed, and the evaluation of appropriate primary prophylactic regimes is a priority.
Tuberculosis infection in HIV-infected Indian patients.
TLDR
It is concluded that TB, a common HIV-related opportunistic infection in Indian subjects, is associated with lower CD4+ counts, and the influence of TB therapy on CD4 counts in the patients needs to be further investigated.
Progression of human immunodeficiency virus infection in patients with tuberculosis disease. A cohort study in Bordeaux, France, 1988-1994. The Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).
TLDR
Tuberculosis disease affected survival but not occurrence of subsequent opportunistic infections or rate of CD4+ count decline, suggesting that tuberculosis may be a marker of advanced HIV and may accelerate its course of infection.
Population differences in death rates in HIV-positive patients with tuberculosis.
  • I. Ciglenecki, J. Glynn, A. Nunn
  • Medicine, Biology
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
  • 2007
TLDR
It is important to understand the reasons for population differences in mortality among patients with TB and HIV and to maximise efforts to reduce mortality.
Smear positive pulmonary tuberculosis among HIV patients receiving highly active antiretroviral therapy in Dar es Salaam, Tanzania.
TLDR
Evidence is provided that development of smear positive PTB after HAART initiation may occur at any level of CD4 lymphocyte count, and more studies involving a larger sample size are recommended in order to estimate more accurately the effect of both level ofCD4 lymphocytes count and HAART.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 16 REFERENCES
Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality.
TLDR
Tuberculosis control programs in developing countries need to implement "short-course" regimens and train health workers to recognize and treat nontuberculous infections to maintain their effectiveness in the face of the HIV epidemic.
Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire.
TLDR
Given their higher relapse rate after 1 yr of "standard" chemotherapy, the public health impact of routine maintenance therapy in HIV seropositive patients with pulmonary TB who complete such therapy should be assessed in comparison to the introduction of rifampicin-based short-course antituberculosis chemotherapy in developing countries.
The mortality and pathology of HIV infection in a West African city
TLDR
In this population, HIV-positive adults present to hospital with advanced disease associated with high mortality, and the three major underlying pathologies (TB, toxoplasmosis and bacteraemia) are either preventable or treatable.
HIV-related morbidity and mortality in sub-Saharan Africa: opportunities for prevention.
TLDR
It is argued that few HIV-infected patients in Africa survive long enough to develop the state of immunodeficiency that allows for the development of Pneumocystis carinii pneumonia, and studies on combined chemoprophylaxis with isoniazid and cotrimoxazole in African HIV- Infected patients may significantly increase survival.
Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival.
TLDR
Response to antituberculosis therapy was favorable in AIDS patients, although adverse drug reactions occurred more frequently than in non-AIDS patients (p less than 0.02).
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.
TLDR
Tuberculosis causes substantial mortality in patients with advanced HIV infection and in patients who comply with the regimen, conventional therapy results in rapid sterilization of sputum, radiographic improvement, and low rates of relapse.
Idiopathic CD4+ T‐lymphocyte depletion in a West African population
TLDR
CD4+ T-lymphocytopenia in HIV-negative individuals was not associated with wasting syndrome or increased mortality, and there was no evidence for frequent, clinically relevant immune deficiency other than that associated with HIV infection.
HIV infection in patients with tuberculosis in Kinshasa, Zaire.
TLDR
With the growing AIDS problem, the serious TB burden in sub-Saharan Africa may become even more onerous and may critically overload the stressed African health care systems.
...
1
2
...